{'fraction_non_alphanumeric': 0.06296603148301574, 'fraction_numerical': 0.06172328086164043, 'mean_word_length': 4.669014084507042, 'pattern_counts': {'":': 0, '<': 3, '<?xml version=': 0, '>': 1, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Abstract 008: Genetic Studies Identify A Novel Role Of
 CCDC93
 In Arterial Relaxation And Central Systolic Blood Pressure


 Previous genome-wide association studies (GWAS) have identified and validated variants at more than 1000 loci with modest effects on population blood pressure (BP), explaining in aggregate ~6% of the trait variance and highlighting genetic differences in BP regulation in ethnically diverse populations. We performed an exome-wide association study (EWAS) in Han Chinese population (N=5,954) from Beijing and identified 4 EWAS single nucleotide polymorphism (SNP)-trait associations with 3 SNPs, including two novel associations (rs2165468-peripheral systolic BP and rs33975708-central systolic BP (cSBP). rs33975708 is a coding variant in the coiled-coil domain containing 93 (
 CCDC93
 ) gene, c.535C>T, p.Arg179Cys (MAF=0.15%) and was associated with substantially increased cSBP (β=29.3 mmHg, P =1.23E-7) in Han Chinese population. CRISPR/Cas9 was used to introduce this variant in mice to investigate vascular molecular mechanisms. While this did not yield a viable mouse with the specific SNP, we did generate mice with an out of frame deletion making a gene knock-out.
 Ccdc93
 deletion (
 Ccdc93
 -/-
 ) in its homozygous form was embryonic lethal (<E10.5).
 Ccdc93
 +/-
 heterozygous mice were viable and morphologically normal and displayed 1.31-fold lower aortic
 Ccdc93
 protein expression (P=0.0041, N=6). Systolic BP was higher in
 Ccdc93
 +/-
 mice (110±8 mmHg vs 125±10 mmHg, P=0.016, N=5-7) and showed impaired acetylcholine (Ach)-induced relaxation (max Ach 86% vs 68%, P<0.03) and enhanced phenylephrine (PE)-induced contraction (max PE 123% vs 198% normalized to KCL response, P<0.03, N=5) in thoracic aorta
 ex vivo
 . Transcriptome analysis by RNA-seq of thoracic aorta identified significantly enriched biological processes in
 Ccdc93
 +/-
 among the pathways altered in fatty acid metabolic process (adjusted P=2.9E-9) together with mitochondrial metabolism (P=1.3E-14). Plasma free fatty acid levels were higher in
 Ccdc93
 +/-
 mice (96±7 μM vs 124±13 μM, P=0.0031, N=6) and aortic parkin protein expression, a marker of mitochondrial dysfunction, was 1.63-fold higher (P=0.028, N=6). In conclusion, our genetic and functional studies indicate a potential novel role of CCDC93 on blood pressure regulation through its effects on vascular mitochondrial function.
